LEADER 05706nam  2200733 a 450 
001 9910457190603321
005 20200520144314.0
010   $a1-283-43410-5
010   $a9786613434104
010   $a0-12-385084-3
035   $a(CKB)2550000000084401
035   $a(EBL)860151
035   $a(OCoLC)775873223
035   $a(SSID)ssj0000629756
035   $a(PQKBManifestationID)12273483
035   $a(PQKBTitleCode)TC0000629756
035   $a(PQKBWorkID)10732711
035   $a(PQKB)11092207
035   $a(MiAaPQ)EBC860151
035   $a(PPN)175614385
035   $a(Au-PeEL)EBL860151
035   $a(CaPaEBR)ebr10525056
035   $a(CaONFJC)MIL343410
035   $a(EXLCZ)992550000000084401
100   $a20120128d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aNutritional and therapeutic interventions for diabetes and metabolic syndrome$b[electronic resource] /$fedited by Debasis Bagchi, Nair Sreejayan
205   $a1st ed.
210   $aAmsterdam $cAcademic Press$d2012
215   $a1 online resource (553 p.)
300   $aDescription based upon print version of record.
311   $a0-12-385083-5 
320   $aIncludes bibliographical references and index.
327   $aFront Cover; Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome; Copyright; Dedication; Contents; Preface; Contributors; SECTION I - EPIDEMIOLOGY AND OVERVIEW; Chapter 1 - Type 1 Diabetes Mellitus: An Overview; INTRODUCTION; DEFINITION; EPIDEMIOLOGY; PATHOPHYSIOLOGY; DIAGNOSIS; CLINICAL PRESENTATION; MANAGEMENT; COMORBIDITIES; COMPLICATIONS; PREVENTION AND INTERVENTION TRIALS; References; Chapter 2 - Overview of Type 2 Diabetes; DEFINITION AND DIAGNOSTIC CRITERIA; EPIDEMIOLOGY OF TYPE 2 DIABETES AND ITS COMPLICATIONS; GENETIC RISK FACTORS FOR TYPE 2 DIABETES
327   $aRISK FACTORS AND SCREENING FOR TYPE 2 DIABETESDIABETES IN PREGNANCY: IMPLICATIONS FOR MOTHER AND OFFSPRING; EVIDENCE FOR METABOLIC PROGRAMMING OF DIABETES IN EARLY LIFE; EARLY INTERVENTION IN TYPE 2 DIABETES; CLINICAL MANAGEMENT OF TYPE 2 DIABETES; TREATMENT GUIDELINES; NUTRITION AND LIFESTYLE INTERVENTION; PHARMACOLOGICAL TREATMENTS; BARIATRIC SURGERY; ECONOMIC IMPACT OF TYPE 2 DIABETES; FUTURE DIRECTIONS; References; Chapter 3 - Pathogenesis of Type 2 Diabetes-A Comprehensive Analysis; INTRODUCTION; GENETICS OF TYPE 2 DIABETES; MAINTENANCE OF NORMAL GLUCOSE HOMEOSTASIS
327   $aIMPAIRED GLUCOSE HOMEOSTASIS IN PATIENTS WITH TYPE 2 DIABETESMECHANISTIC ACTIONS WHICH LEAD TO PROGRESSIVE ?-CELL FAILURE AND TYPE 2 DIABETES; SUMMARY; References; Chapter 4 - Managing the Broad Spectrum of Type 2 Diabetes; INTRODUCTION; EVOLVING PATHOPHYSIOLOGY OF TYPE 2 DIABETES; ALTERING THE PROGRESSION OF TYPE 2 DIABETES; NEED FOR EARLY INTERVENTION; AGGRESSIVE MANAGEMENT AFTER DIAGNOSIS; HOW LOW DO WE GO FOR GLYCEMIC CONTROL?; TREATMENT OPTIONS; SELF-MANAGEMENT EDUCATION; LIFESTYLE MODIFICATION; MEAL PLANNING; PHYSICAL ACTIVITY; PHARMACOLOGICAL TREATMENT; WHEN TO ADJUST TREATMENT
327   $aINITIATING INSULIN THERAPYINSULIN DELIVERY DEVICES; CONCLUSIONS; References; Chapter 5 - Prediabetes: Prevalence, Pathogenesis, and Recognition of Enhanced Risk; BACKGROUND; PREVALENCE; RESULTS; PATHOGENESIS; RECOGNITION OF ENHANCED RISK; MEANS FOR CARDIOMETABOLIC RISK FACTORS; DISCUSSION; CONCLUSION; References; Chapter 6 - Obesity and Type 2 Diabetes in Youths: New Challenges to Overcome; OBESITY: THE 21ST CENTURY EPIDEMIC; METABOLIC COMPLICATIONS OF OBESITY IN CHILDREN AND ADOLESCENTS; TYPE 2 DIABETES IN CHILDREN AND ADOLESCENCE: A NEW FRIGHTENING EPIDEMIC?
327   $aPATHOGENESIS OF TYPE 2 DIABETES IN OBESE CHILDREN AND ADOLESCENTSROLE OF ECTOPIC FAT DEPOSITION IN THE PATHOGENESIS OF INSULIN RESISTANCE; THE ?-CELL IN THE STORM OF INSULIN RESISTANCE; THERAPY OF TYPE 2 DIABETES IN YOUTHS; CONCLUSIONS AND FUTURE PERSPECTIVES; References; Chapter 7 - Diabetes Pathophysiology: A Nutritional Perspective; INTRODUCTION; DIETARY TREATMENT FOR DIABETES AT THE TURN OF THE 20TH CENTURY; DIETARY RECOMMENDATIONS; GLUCOSE CONTROL; LOW-CARBOHYDRATE DIETS; CONCLUSIONS; References; Chapter 8 - Diabetes Mellitus: A Nursing Perspective; INTRODUCTION/OVERVIEW
327   $aNURSING PERSPECTIVE
330   $aDiabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years and numerous epidemiologic studies have demonstrated that type 2 diabetes increases the risk of cardiovascular morbidity and mortality. It is estimated to cost over 92 BILLION in health care costs and lost productivity. The increased risk is due to the detrimental vascular effects of prolonged exposure to a hyperglycemic, oxidant rich environment yielding associated cardiovascular risk factors: atherosclerosis, hypertension and clot
606   $aDiabetes$xNutritional aspects
606   $aDiabetes$xTreatment
606   $aMetabolic syndrome$xNutritional aspects
606   $aMetabolic syndrome$xTreatment
608   $aElectronic books.
615  0$aDiabetes$xNutritional aspects.
615  0$aDiabetes$xTreatment.
615  0$aMetabolic syndrome$xNutritional aspects.
615  0$aMetabolic syndrome$xTreatment.
676   $a616.398
676   $a616.4620654
701   $aBagchi$b Debasis$0857473
701   $aSreejayan$b Nair$0868891
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457190603321
996   $aNutritional and therapeutic interventions for diabetes and metabolic syndrome$91939787
997   $aUNINA